DDI-DrugBank.d777.s0 >> The interaction of Streptase, Streptokinase, with other drugs has not been well studied. >> 19-27,30-42
DDI-DrugBank.d777.s1 >> Use of Anticoagulants and Antiplatelet Agents -- Streptase, Streptokinase, alone or in combination with antiplatelet agents and anticoagulants, may cause bleeding complications. >> 7-20,26-44,49-57,60-72,104-122,128-141
DDI-DrugBank.d777.s2 >> Therefore, careful monitoring is advised.
DDI-DrugBank.d777.s3 >> In the treatment of acute MI, aspirin, when not otherwise contraindicated, should be administered with Streptokinase ( see below ). >> 30-36,103-115
DDI-DrugBank.d777.s4 >> Anticoagulation and Antiplatelets After Treatment for Myocardial Infarction -- In the treatment of acute myocardial infarction, the use of aspirin has been shown to reduce the incidence of reinfarction and stroke. >> 20-32,139-145
DDI-DrugBank.d777.s5 >> The addition of aspirin to Streptokinase causes a minimal increase in the risk of minor bleeding (3.9% vs. 3.1%), but does not appear to increase the incidence of major bleeding (see >> 16-22,27-39
